A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma
Latest Information Update: 30 Oct 2024
At a glance
- Drugs Zevorcabtagene autoleucel (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Sponsors CARsgen
Most Recent Events
- 30 Oct 2024 New trial record